Biote Q4 2023 GAAP EPS $0.18 Beats $0.08 Estimate, Sales $45.703M Miss $45.740M Estimate
Portfolio Pulse from Benzinga Newsdesk
Biote (NASDAQ:BTMD) reported Q4 2023 earnings of $0.18 per share, surpassing the $0.08 estimate, but its sales of $45.703M slightly missed the $45.740M estimate. Year-over-year, earnings remained stable while sales grew by 2.74%.
March 12, 2024 | 8:13 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Biote's Q4 2023 earnings beat estimates with an EPS of $0.18, but sales slightly missed expectations. Earnings remained stable, and sales saw a modest year-over-year growth.
The positive earnings surprise, beating estimates by 125%, is likely to be viewed favorably by investors, potentially leading to a short-term uptick in BTMD's stock price. The slight miss in sales is minor and unlikely to significantly dampen investor sentiment, especially given the year-over-year sales growth.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100